Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission

Kedra Joanna 1 Philippe Dieudé 2, 1 Hubert Marotte 3, 1 Alexandre Lafourcade 4, 1 Emilie Ducourau 5, 1 Thierry Schaeverbeke 6, 1 Aleth Perdriger 7, 1 Martin Soubrier 8, 1 Jacques Morel 9, 1 Arnaud Constantin 10, 1 Emmanuelle Dernis 11, 1 Valérie Royant 12, 1 Jean-Hugues Salmon 13, 1 Thao Pham 14, 1 Jacques-Eric Gottenberg 15, 1 Edouard Pertuiset 16, 1 Maxime Dougados 17, 1 Valérie Devauchelle-Pensec 18, 1 Philippe Gaudin 19, 1 Gregoire Cormier 20, 1 Philippe Goupille 21, 1 Xavier Mariette 22, 1 Francis Berenbaum 23, 1 Didier Alcaix 1 Sid Ahmed Rouidi 24, 1 Jean-Marie Berthelot 25, 1 Agnès Monnier 1 Christine Piroth 26, 1 Frederic Liote 27, 1 Vincent Goeb 28, 1 Cécile Gaujoux-Viala 1 Isabelle Chary Valckenaere 1 David Hajage 29, 1 Florence Tubach 30, 1 Bruno Fautrel 31, 1
Document type :
Poster communications
Complete list of metadatas

https://hal.univ-brest.fr/hal-02158682
Contributor : Geneviève Michel <>
Submitted on : Tuesday, June 18, 2019 - 11:39:27 AM
Last modification on : Friday, September 6, 2019 - 10:15:28 AM

Identifiers

  • HAL Id : hal-02158682, version 1

Citation

Kedra Joanna, Philippe Dieudé, Hubert Marotte, Alexandre Lafourcade, Emilie Ducourau, et al.. Towards the lowest efficacious dose (toledo): results of a multicenter non-inferiority randomized open-label controlled trial assessing tocilizumab or abatacept injection spacing in rheumatoid arthritis patients in remission. EULAR 2019, Jun 2019, MADRID, Spain. ⟨hal-02158682⟩

Share

Metrics

Record views

52